Li Xiao C, Shull Gary E, Miguel-Qin Elisa, Zhuo Jia L
Laboratory of Receptor and Signal Transduction, Department of Pharmacology and Toxicology; Division of Nephrology, Department of Medicine; University of Mississippi Medical Center, Jackson, Mississippi; and.
Department of Molecular Genetics, University of Cincinnati College of Medicine, Cincinnati, Ohio.
Physiol Genomics. 2015 Oct;47(10):479-87. doi: 10.1152/physiolgenomics.00056.2015. Epub 2015 Aug 4.
The renal mechanisms responsible for angiotensin II (ANG II)-induced hypertension remain incompletely understood. The present study tested the hypothesis that the Na(+)/H(+) exchanger 3 (NHE3) is required for ANG II-induced hypertension in mice. Five groups of wild-type (Nhe3(+/+)) and Nhe3(-/-) mice were treated with vehicle or high pressor doses of ANG II (1.5 mg/kg/day ip, via minipump for 2 wk, or 10 pmol/min iv for 30 min). Under basal conditions, Nhe3(-/-) mice had significantly lower systolic blood pressure (SBP) and mean intra-arterial pressure (MAP) (P < 0.01), 24 h urine (P < 0.05), urinary Na(+) (P < 0.01) and urinary K(+) excretion (P < 0.01). In response to ANG II, SBP and MAP markedly increased in Nhe3(+/+) mice in a time-dependent manner, as expected (P < 0.01). However, these acute and chronic pressor responses to ANG II were significantly attenuated in Nhe3(-/-) mice (P < 0.01). Losartan blocked ANG II-induced hypertension in Nhe3(+/+) mice but induced marked mortality in Nhe3(-/-) mice. The attenuated pressor responses to ANG II in Nhe3(-/-) mice were associated with marked compensatory humoral and renal responses to genetic loss of intestinal and renal NHE3. These include elevated basal plasma ANG II and aldosterone and kidney ANG II levels, salt wasting from the intestines, increased renal AQP1, Na(+)/HCO3 (-), and Na(+)/K(+)-ATPase expression, and increased PKCα, mitogen-activated protein kinases ERK1/2, and glycogen synthase kinase 3αβ signaling proteins in the proximal tubules (P < 0.01). We concluded that NHE3 in proximal tubules of the kidney, along with NHE3 in intestines, is required for maintaining basal blood pressure as well as the full development of ANG II-induced hypertension.
肾素-血管紧张素系统(RAS)在高血压发病机制中的作用尚不完全清楚。本研究旨在探讨肾素-血管紧张素系统(RAS)在高血压发病机制中的作用。我们将野生型(WT)和肾素-血管紧张素系统(RAS)基因敲除(KO)小鼠分为5组,分别给予生理盐水或高剂量的血管紧张素Ⅱ(ANGⅡ)(1.5mg/kg/d,腹腔注射,持续2周;或10pmol/min,静脉注射,持续30min)。在基础状态下,RAS基因敲除小鼠的收缩压(SBP)、平均动脉压(MAP)、24小时尿钠排泄量、尿钠排泄分数和尿钾排泄分数均显著低于野生型小鼠(P<0.01)。给予ANGⅡ后,野生型小鼠的SBP和MAP均显著升高,且呈时间依赖性(P<0.01)。然而,RAS基因敲除小鼠对ANGⅡ的急性和慢性升压反应均显著减弱(P<0.01)。氯沙坦可阻断野生型小鼠ANGⅡ诱导的高血压,但可导致RAS基因敲除小鼠显著死亡。RAS基因敲除小鼠对ANGⅡ的升压反应减弱与肠道和肾脏RAS基因缺失后的显著代偿性体液和肾脏反应有关。这些反应包括基础血浆ANGⅡ和醛固酮水平升高、肾脏ANGⅡ水平升高、肠道失盐、肾脏水通道蛋白1(AQP1)、钠/碳酸氢根转运体(Na+/HCO3-)和钠/钾-ATP酶表达增加,以及近端肾小管蛋白激酶Cα(PKCα)、丝裂原活化蛋白激酶ERK1/2和糖原合酶激酶3αβ信号蛋白增加(P<0.01)。我们的结论是,肾脏近端小管中的RAS以及肠道中的RAS对于维持基础血压以及ANGⅡ诱导的高血压的充分发展是必需的。